Principal Financial Group Inc Eli Lilly & CO Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Principal Financial Group Inc holds 1,217,565 shares of LLY stock, worth $1.1 Billion. This represents 0.58% of its overall portfolio holdings.

Number of Shares

1,217,565

Previous 1,224,134 0.54%

Holding current value

$1.1 Billion

Previous $714 Million 32.74%

% of portfolio

0.58%

Previous 0.48%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $3.89 Million - $5.2 Million	-6,569 Reduced 0.54%	1,217,565 $947 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $12.2 Million - $14.3 Million	-23,177 Reduced 1.86%	1,224,134 $714 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $3.26 Million - $4.49 Million	7,494 Added 0.6%	1,247,311 $670 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $4.29 Million - $5.73 Million	-12,227 Reduced 0.98%	1,239,817 $581 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $16.4 Million - $19.2 Million	-52,648 Reduced 4.04%	1,252,044 $430 Million

Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $9.88 Million - $11.5 Million	-30,725 Reduced 2.3%	1,304,692 $477 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $17.8 Million - $20.2 Million	59,876 Added 4.69%	1,335,417 $432 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $44.9 Million - $52.7 Million	-160,986 Reduced 11.21%	1,275,541 $414 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $4.48 Million - $5.57 Million	-19,096 Reduced 1.31%	1,436,527 $411 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $6.37 Million - $7.9 Million	28,315 Added 1.98%	1,455,623 $402 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $21.2 Million - $26.1 Million	95,767 Added 7.19%	1,427,308 $330 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $10.4 Million - $13.5 Million	57,769 Added 4.54%	1,331,541 $306 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $2.69 Million - $3.49 Million	-16,396 Reduced 1.27%	1,273,772 $238 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $20.1 Million - $26.6 Million	-153,948 Reduced 10.66%	1,290,168 $218 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $16.7 Million - $19.3 Million	-114,029 Reduced 7.32%	1,444,116 $214 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $43.5 Million - $52.4 Million	319,133 Added 25.76%	1,558,145 $256 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $3.97 Million - $4.91 Million	33,312 Added 2.76%	1,239,012 $172 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $27.1 Million - $33.5 Million	-253,011 Reduced 17.34%	1,205,700 $158 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $5.61 Million - $6.1 Million	-52,545 Reduced 3.48%	1,458,711 $163 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $4.61 Million - $5.39 Million	-41,646 Reduced 2.68%	1,511,256 $167 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $20.3 Million - $23.9 Million	-182,092 Reduced 10.5%	1,552,902 $202 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $27.1 Million - $30.3 Million	255,461 Added 17.27%	1,734,994 $201 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $3 Million - $3.75 Million	34,935 Added 2.42%	1,479,533 $159 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $27.5 Million - $31.6 Million	-363,349 Reduced 20.1%	1,444,598 $0
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $10.3 Million - $12.2 Million	138,746 Added 8.31%	1,807,947 $140 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $14.5 Million - $15.6 Million	177,006 Added 11.86%	1,669,201 $141 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $115 Million - $128 Million	1,492,195	1,492,195 $128 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Eli Lilly & CO Transaction History